ECDC risk assessment: 2009 influenza A(H1N1) pandemic (Update 17 December 2009)
This update of the ECDC pandemic risk assessment for Europe is based on data and analyses available in early December 2009. It draws on the experience in European countries, North America and the Southern Hemisphere’s temperate countries, which have already passed through a winter with the new virus. This description deals with the infection and the disease. Specifically, it does not include comments on the pharmaceutical countermeasures, nor their likely effectiveness and safety. These are dealt with separately in dedicated ECDC documents.
Threat Assessment Brief: Emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA
11 May 2021 - The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage B.1.617.2.
Threat Assessment Brief: Dengue epidemic in Réunion, 2021
5 May 2021 - This document assesses the risk related to dengue for EU/EEA citizens travelling to or residing in Réunion, and the risk related to having an outbreak of dengue in mainland EU/EEA following introduction of the virus from Réunion.
Risk Assessment: Emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries
17 Mar 2021 - This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).